Myricetin weakened the cancer cells neoplastic transformation by interacting with oncoproteins such as protein kinase B (PKB) (Akt), Fyn, Janus kinase‐signals and activation of JAK1‐STAT3 MEK1. The gene discussed is AKT1; the disease is cancer.